Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Sales | 885,245 | 1,014,464 | 1,036,992 | 832,548 | 342,406 |
Cost of Goods | 215,062 | 241,509 | 251,640 | 200,995 | 100,368 |
Gross Profit | 670,183 | 772,955 | 785,352 | 631,553 | 242,038 |
Operating Expenses | 475,928 | 540,377 | 454,449 | 494,033 | 402,424 |
Operating Income | 194,317 | 233,087 | 331,543 | 138,515 | -160,018 |
Interest Expense | 21,256 | 22,045 | 22,977 | 22,581 | 13,460 |
Other Income | -322 | 13 | -1,325 | -301 | 2,376 |
Pre-tax Income | 172,739 | 211,055 | 307,241 | 115,633 | -171,102 |
Income Tax | -31,522 | 37,873 | -19,302 | -42,484 | -47,751 |
Net Income Continuous | 204,261 | 173,182 | 326,543 | 158,117 | -123,351 |
Net Income | $204,261 | $173,182 | $326,543 | $158,117 | $-123,351 |
EPS Basic Total Ops | 0.89 | 0.78 | 1.44 | 0.70 | -0.55 |
EPS Basic Continuous Ops | 0.89 | 0.77 | 1.44 | 0.70 | -0.55 |
EPS Diluted Total Ops | 0.87 | 0.77 | 1.38 | 0.67 | -0.55 |
EPS Diluted Continuous Ops | 0.87 | 0.76 | 1.38 | 0.67 | -0.55 |
EPS Diluted Before Non-Recurring Items | 1.34 | 1.41 | 1.75 | N/A | N/A |
EBITDA(a) | $291,006 | $331,071 | $427,523 | $231,898 | $-88,425 |